Paydirt
AM
Insider

Andrew J Murphy

Co-Chief Scientific Officer · Regeneron Pharmaceuticals

Andrew J Murphy (Co-Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $2.6M of REGN (3,352 sh across 11 lots, as filed), executed Oct 14. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.6M
shares × price, as filed
Last traded
Oct 14
Filed Oct 15

Median ADV $702.3M across their filed names

Open performance→
Volume by month
$2.6M$1.3M$0Dec 2024Jun 2025Dec 2025Jun 2026Oct 2026 · sells $2.6M
Buys $0 Sells $2.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
REGN Regeneron Pharmaceuticals, Inc. REGN · 0 buys · 1 sell 1 filing
Recent filings
REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $2.6M
3,352 sh across 11 lots
Exec Oct 14
Filed Oct 15 · 4:02 PM ET